Rockford woman is 1st in Wisconsin to receive newly-approved FDA ALS treatment
-
2:14
7 Candidates, 5 minutes each: Democrats make their pitch for...
-
0:42
Kids sharpen their skills with Packers Micah Parsons in Greenfield
-
0:50
’My eyes welled up with tears’: Tribute Tournament held in...
-
2:23
‘It’s overwhelmingly emotional’: Germantown honey farm’s...
-
3:26
Meet the artist behind West Allis’ newest mural inspired by...
-
7:28
’It can be something you live with’: The progress in Wisconsin...
-
2:57
Goodbye, heat, for a while. Seasonably cool weather on the way...
-
2:30
Can a democratic trifecta happen? Party leaders say yes, highlight...
-
1:01
NFL Milwaukee natives team up in second annual youth football...
-
1:28
Family identifies victim after reported drowning in Nagawicka...
-
1:37
Hundreds of local mothers, families receive free resources during...
-
3:05
One day of showers, storms to dodge this weekend
ROCKFORD, Ill. (CBS 58) -- A Rockford, Illinois woman is the first in Wisconsin to receive a new FDA-approved treatment for ALS, or Lou Gehrig's disease.
Michelle Francis was first diagnosed in 2019 with what's called the SOD1 mutation.
The disease has run in her family for seven generations, affecting 65 members and counting.
In April, UW Health in Madison offered a glimmer of hope -- a monthly treatment involved removing spinal fluid with a needle and replacing it with a new drug.
Now, nearly eight appointments later, Francis says she has hope for the first time.
"It will be here forever so we definitely have to have something to once you develop, there's some hope and I’m thinking this is gonna be it," said Francis.
Francis says she hopes others with ALS will hear her story, be inspired, and most importantly, not give up.